Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
Kidney Int Rep
.
2021 Sep;6(9):2468-2471.
doi: 10.1016/j.ekir.2021.06.012.
Epub 2021 Jun 26.
Authors
Muhammad Y Jan
1
,
Skye E Sayegh
1
,
Hanna T Webb
1
,
Oluwafisayo Adebiyi
1
,
Melissa D Anderson
1
,
Dennis P Mishler
1
,
Muhammad S Yaqub
1
,
Tim Taber
1
,
Asif A Sharfuddin
1
Affiliation
1
Division of Nephrology and Hypertension, Indiana University School of Medicine, Indianapolis, Indiana, USA.
PMID:
34222731
PMCID:
PMC8233547
DOI:
10.1016/j.ekir.2021.06.012
No abstract available